NCT07490015

Brief Summary

This is a retrospective and prospective multi-center observational study of the management and outcomes of BTAI. This study will include patients who meet the registry inclusion criteria as documented in EPIC and chart review will start from January 2019 and December 2028. Data and endpoints will be observational and involve no prescribed therapeutic interventions or alterations in patient care. Institutions and providers will conduct normal diagnosis, management, and surveillance procedures without interference of this study.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
29mo left

Started Apr 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress50%
Apr 2024Dec 2028

Study Start

First participant enrolled

April 8, 2024

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

March 18, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 24, 2026

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

June 25, 2026

Status Verified

June 1, 2026

Enrollment Period

4.7 years

First QC Date

March 18, 2026

Last Update Submit

June 23, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • The primary objective of this study is to establish a database of information that will allow the presentation, diagnosis, management, and outcomes of BTAI to be analyzed.

    January 2019 and December 2028

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

• ≥ 18 years old

You may qualify if:

  • ≥ 18 years old
  • Computed tomography (CT)/CT angiography, angiographic, or intravascular ultrasound diagnosis of injury of the thoracic aorta

You may not qualify if:

  • \< 18 years old
  • Patients without a diagnosis of vascular injury
  • Patients who were initially treated for their vascular injury at a prior medical facility

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Methodist Dallas Medical Center

Dallas, Texas, 75203, United States

Location

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
30 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 18, 2026

First Posted

March 24, 2026

Study Start

April 8, 2024

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

June 25, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations